Ankrah, Alfred O.; Buscombe, John Richard; Sathekge, Mike Machaba(Clinics Cardiv, 2012-07)
BACKGROUND: Elevated plasma homocysteine level has emerged as a relatively newly recognised risk factor for coronary artery disease (CAD). However, reduction of plasma homocysteine levels in large prospective studies did ...
Sathekge, Mike Machaba; Buscombe, John Richard(Lippincott Williams & Wilkins, 2011-04)
Much is written about the transfer of technology from
developed to developing countries. In the area of health
care, not only the issue of poverty within the developing
countries is there but also the pattern and ...
Jamar, Francois; Buscombe, John Richard; Chiti, Arturo; Christian, Paul E.; Delbeke, Dominique; Donohoe, Kevin J.; Israel, Ora; Martin-Comin, Josep; Signore, Alberto(Society of Nuclear Medicine, Inc., 2013-01-28)
The Society of Nuclear Medicine and Molecular Imaging
(SNMMI) is an international scientific and professional
organization founded in 1954 to promote the science,
technology and practical application of nuclear ...
The development of peptide receptor radionuclide therapy (PRRT) in disseminated neuroendocrine tumors (NETs) has been a long and protracted process. The idea was born within nuclear medicine academia but its translation ...
Buscombe, John Richard(British Institute of Radiology, 2015)
Positron emission tomography (PET) has become widely established in oncology. Subsequently, a whole new “toolbox” of
tracers have become available to look at different aspects of cancer cell function and dysfunction, ...
